ghk-cu clinical trials ghk cu human studies dosage or trial dose Peptide Chart: Complete Reference Tables for Every Protocol Copper Peptide (GHK-Cu): Clinical Uses, – ghk cu human clinical trials – ghk-cu clinical trials dosage trial

JAMA Neurol 70(9):11981200

Autoimmune with no specific causal infectious agent identified: Guillain-Barr Syndrome / Acute Inflammatory Demyelinating Polyneuropathy (AIDP) Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Associated with hepatitis Behet disease Scleroderma Inflammatory bowel diseases Systemic Lupus Erythematosus (Lupus) Psoriasis / Psoriatic arthritis Sjgrens Syndrome Multifocal Motor Neuropathy (MMN) Peripheral Neuropathy Associated with Protein Abnormalities Tests (Not all evaluation and tests may be necessary) Comprehensive foot exam Physical examination Neurological exam Electromyography Nerve conduction velocity test Quantitive sensory testing (QST) Nerve or skin biopsy Blood studies (to verify diabetes (e.g., HbA1C) and to rule out other potential causes) Treatments (Not all treatments and therapies may be indicated) The goal of treatment for diabetic neuropathy is to relieve discomfort and to prevent further tissue damage

So you have a clear, easy to follow plan on how to help your pet finally feel their best again

This is not a prescribe-and-disappear model